Magventure
Transcranial Magnetic Stimulators.
-
TMS Certification Course
3 min Express TMS is advantageous for social distancing
In recent years, Dr. Miller has increasingly used the Theta Burst (or Express TMS®) protocol for his depression patients, a protocol which cuts treatment time from the standard 37 or 19 minutes down to just 3 minutes per session. The safety and efficacy of TBS have been documented in the largest randomized controlled TMS trial to date, known as the THREE-D trial from 2018, which compared the standard 37 minute protocol with the 3 minute Theta Burst (TBS) protocol.
European Clinical TMS Certification Course
Transcranial magnetic stimulation, in short TMS, has proved to be clinically effective in treating neuropsychiatric disorders such as depression and obsessive compulsive disorder. This certified and accredited TMS Certification Course provides excellent training on how to use repetitive TMS (rTMS) in psychiatry, neurology, and rehabilitation.
Phoenix Mental Health Services, UK: TMS adds more choices for the patient
“At the recommendation of a colleague, we added TMS in 2018 as a treatment option for depression. TMS is a way for us to add more choices for the patients, as it provides a viable option to patients who are either treatment-resistant to pharmaceuticals or who do not tolerate the side effects of antidepressants.”
MagVenture receives FDA clearance for OCD
FDA has cleared MagVenture TMS Therapy® for adjunct treatment of Obsessive-Compulsive Disorder (OCD). This marks MagVenture's second indication in the US . MagVenture TMS Therapy is already FDA cleared for the treatment of major depressive disorder.
Applications of Non-invasive Neuromodulation for the Management of Disorders Related to COVID-19
Background: Novel coronavirus disease (COVID-19) morbidity is not restricted to the respiratory system, but also affects the nervous system. Non-invasive neuromodulation may be useful in the treatment of the disorders associated with COVID-19. Objective: To describe the rationale and empirical basis of the use of non-invasive neuromodulation in the management of patients with COVID-10 and related disorders.
Repetitive transcranial magnetic stimulation of the prefrontal cortex for fibromyalgia syndrome: a randomised controlled trial with 6-months follow up
Fibromyalgia Syndrome (FMS), is a chronic pain disorder with poorly understood pathophysiology. In recent years, repetitive transcranial magnetic stimulation (rTMS) has been recommended for pain relief in various chronic pain disorders. The objective of the present research was to study the effect of low frequency rTMS over the right dorsolateral prefrontal cortex (DLPFC) on pain status in FMS.
Perspectives on the use of neuromodulation in Covid-19
By: Professor Abrahão F. Baptista, Universidade Federal do ABC, Brazil
Tips & Tricks to set up a TMS Practice
How to choose the correct system, facility recommendations, communication, TMS Therapy and business plan.
Introduction to TMS – from research to clinical application
History, principles and evidence of TMS, approved protocols, cost effectiveness of TMS.
Methodology for characterizing network activations with neuro-navigated TMS and EEG
This article walks users through the collection of neuro-navigated simultaneously obtained Transcranial Magnetic Stimulation (TMS) evoked EEG (TMS-EEG) data to investigate network-specific TMS-induced EEG activations, as in Ozdemir et al. 2020, focusing specifically on the methods of TMS-EEG data collection and analysis.
National CME & TMS training workshop
5 NATIONAL CME & 2 HANDS-ON-TRAINING WORKSHOP ON TMS - DECEMBER 17-18TH, 2020, orgnised by Department Of Psychiatry, Aiims New Delhi with Neuromodulation Society, India and Indian Psychiatric Society
FDA clearance for MagVenture: 3 minute depression treatment
For people suffering from severe depression, the road to remission just became a lot shorter: The treatment is known as Transcranial Magnetic Stimulation (TMS), and MagVenture has now, as the only company in the US, received FDA clearance for a newer and much faster treatment protocol which will cut down treatment time to just 3 minutes per session*. Before that, the required treatment time per session was up to 37 minutes.
3 min Express TMS is advantageous for social distancing
In recent years, Dr. Miller has increasingly used the Theta Burst (or Express TMS®) protocol for his depression patients, a protocol which cuts treatment time from the standard 37 or 19 minutes down to just 3 minutes per session. The safety and efficacy of TBS have been documented in the largest randomized controlled TMS trial to date, known as the THREE-D trial from 2018, which compared the standard 37 minute protocol with the 3 minute Theta Burst (TBS) protocol.
European Clinical TMS Certification Course
Transcranial magnetic stimulation, in short TMS, has proved to be clinically effective in treating neuropsychiatric disorders such as depression and obsessive compulsive disorder. This certified and accredited TMS Certification Course provides excellent training on how to use repetitive TMS (rTMS) in psychiatry, neurology, and rehabilitation.
Phoenix Mental Health Services, UK: TMS adds more choices for the patient
“At the recommendation of a colleague, we added TMS in 2018 as a treatment option for depression. TMS is a way for us to add more choices for the patients, as it provides a viable option to patients who are either treatment-resistant to pharmaceuticals or who do not tolerate the side effects of antidepressants.”
MagVenture receives FDA clearance for OCD
FDA has cleared MagVenture TMS Therapy® for adjunct treatment of Obsessive-Compulsive Disorder (OCD). This marks MagVenture's second indication in the US . MagVenture TMS Therapy is already FDA cleared for the treatment of major depressive disorder.
Methodology for characterizing network activations with neuro-navigated TMS and EEG
This article walks users through the collection of neuro-navigated simultaneously obtained Transcranial Magnetic Stimulation (TMS) evoked EEG (TMS-EEG) data to investigate network-specific TMS-induced EEG activations, as in Ozdemir et al. 2020, focusing specifically on the methods of TMS-EEG data collection and analysis.
European Clinical TMS Certification Course
Transcranial magnetic stimulation, in short TMS, has proved to be clinically effective in treating neuropsychiatric disorders such as depression and obsessive compulsive disorder. This certified and accredited TMS Certification Course provides excellent training on how to use repetitive TMS (rTMS) in psychiatry, neurology, and rehabilitation.
Perspectives on the use of neuromodulation in Covid-19
By: Professor Abrahão F. Baptista, Universidade Federal do ABC, Brazil
Tips & Tricks to set up a TMS Practice
How to choose the correct system, facility recommendations, communication, TMS Therapy and business plan.
Introduction to TMS – from research to clinical application
History, principles and evidence of TMS, approved protocols, cost effectiveness of TMS.
National CME & TMS training workshop
5 NATIONAL CME & 2 HANDS-ON-TRAINING WORKSHOP ON TMS - DECEMBER 17-18TH, 2020, orgnised by Department Of Psychiatry, Aiims New Delhi with Neuromodulation Society, India and Indian Psychiatric Society
Applications of Non-invasive Neuromodulation for the Management of Disorders Related to COVID-19
Background: Novel coronavirus disease (COVID-19) morbidity is not restricted to the respiratory system, but also affects the nervous system. Non-invasive neuromodulation may be useful in the treatment of the disorders associated with COVID-19. Objective: To describe the rationale and empirical basis of the use of non-invasive neuromodulation in the management of patients with COVID-10 and related disorders.
Repetitive transcranial magnetic stimulation of the prefrontal cortex for fibromyalgia syndrome: a randomised controlled trial with 6-months follow up
Fibromyalgia Syndrome (FMS), is a chronic pain disorder with poorly understood pathophysiology. In recent years, repetitive transcranial magnetic stimulation (rTMS) has been recommended for pain relief in various chronic pain disorders. The objective of the present research was to study the effect of low frequency rTMS over the right dorsolateral prefrontal cortex (DLPFC) on pain status in FMS.
FDA clearance for MagVenture: 3 minute depression treatment
For people suffering from severe depression, the road to remission just became a lot shorter: The treatment is known as Transcranial Magnetic Stimulation (TMS), and MagVenture has now, as the only company in the US, received FDA clearance for a newer and much faster treatment protocol which will cut down treatment time to just 3 minutes per session*. Before that, the required treatment time per session was up to 37 minutes.
We provide solutions for healthcare and research. We distribute medical equipment, provide scientific expertise and support to researcher